Total Payments
$62,687
2021 Payments
$11,500
Companies
7
Transactions
63
Medicare Patients
164
Medicare Billing
$25,037
Payment Breakdown by Category
Consulting$35,090 (56.0%)
Travel$18,515 (29.5%)
Other$7,881 (12.6%)
Food & Beverage$1,200 (1.9%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $35,090 | 7 | 56.0% |
| Travel and Lodging | $18,515 | 22 | 29.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,881 | 3 | 12.6% |
| Food and Beverage | $1,200 | 31 | 1.9% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $34,381 | 22 | $0 (2021) |
| VERTEX PHARMACEUTICALS INCORPORATED | $17,412 | 11 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $4,852 | 9 | $0 (2021) |
| Boehringer Ingelheim International GmbH | $2,953 | 2 | $0 (2020) |
| Mylan Specialty L.P. | $2,327 | 17 | $0 (2020) |
| Horizon Pharma plc | $750.00 | 1 | $0 (2017) |
| Mallinckrodt LLC | $11.51 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2021 | $11,500 | 2 | Gilead Sciences, Inc. ($7,500) |
| 2020 | $10,208 | 20 | VERTEX PHARMACEUTICALS INCORPORATED ($4,928) |
| 2019 | $21,829 | 28 | VERTEX PHARMACEUTICALS INCORPORATED ($12,144) |
| 2018 | $8,926 | 6 | Gilead Sciences, Inc. ($8,586) |
| 2017 | $10,224 | 7 | Gilead Sciences Inc ($9,463) |
All Payment Transactions
63 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/23/2021 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $4,000.00 | General |
| 05/05/2021 | Gilead Sciences, Inc. | — | Consulting Fee | Cash or cash equivalent | $7,500.00 | General |
| 09/21/2020 | Boehringer Ingelheim International GmbH | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $2,654.61 | General |
| 09/04/2020 | Boehringer Ingelheim International GmbH | SPIRIVA RESPIMAT (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | In-kind items and services | $298.71 | General |
| Category: RESPIRATORY | ||||||
| 04/14/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Travel and Lodging | Cash or cash equivalent | $48.77 | General |
| Category: Respiratory and Allergy | ||||||
| 04/14/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Food and Beverage | In-kind items and services | $45.61 | General |
| Category: Respiratory and Allergy | ||||||
| 04/14/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Food and Beverage | In-kind items and services | $31.70 | General |
| Category: Respiratory and Allergy | ||||||
| 04/14/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Food and Beverage | In-kind items and services | $6.52 | General |
| Category: Respiratory and Allergy | ||||||
| 04/14/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: Respiratory and Allergy | ||||||
| 04/14/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Food and Beverage | In-kind items and services | $5.36 | General |
| Category: Respiratory and Allergy | ||||||
| 04/14/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Food and Beverage | In-kind items and services | $3.62 | General |
| Category: Respiratory and Allergy | ||||||
| 02/01/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Travel and Lodging | Cash or cash equivalent | $74.88 | General |
| Category: Respiratory and Allergy | ||||||
| 02/01/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Travel and Lodging | Cash or cash equivalent | $47.13 | General |
| Category: Respiratory and Allergy | ||||||
| 01/31/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Travel and Lodging | Cash or cash equivalent | $149.59 | General |
| Category: Respiratory and Allergy | ||||||
| 01/31/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Respiratory and Allergy | ||||||
| 01/30/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Travel and Lodging | Cash or cash equivalent | $148.91 | General |
| Category: Respiratory and Allergy | ||||||
| 01/30/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Food and Beverage | In-kind items and services | $93.76 | General |
| Category: Respiratory and Allergy | ||||||
| 01/29/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Travel and Lodging | Cash or cash equivalent | $148.54 | General |
| Category: Respiratory and Allergy | ||||||
| 01/29/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Travel and Lodging | Cash or cash equivalent | $74.27 | General |
| Category: Respiratory and Allergy | ||||||
| 01/29/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Travel and Lodging | Cash or cash equivalent | $46.75 | General |
| Category: Respiratory and Allergy | ||||||
| 01/15/2020 | VERTEX PHARMACEUTICALS INCORPORATED | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $4,928.00 | General |
| 01/10/2020 | Mylan Specialty L.P. | TOBI Podhaler (Drug), TOBI | Travel and Lodging | Cash or cash equivalent | $1,378.14 | General |
| Category: Respiratory and Allergy | ||||||
| 12/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Travel and Lodging | In-kind items and services | $115.00 | General |
| 12/04/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $35.00 | General |
| 11/09/2019 | VERTEX PHARMACEUTICALS INCORPORATED | — | Travel and Lodging | In-kind items and services | $386.57 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 39 | 61 | $18,720 | $5,434 |
| 2022 | 5 | 67 | 118 | $40,523 | $11,961 |
| 2021 | 1 | 17 | 31 | $9,374 | $3,399 |
| 2020 | 3 | 41 | 60 | $13,117 | $4,243 |
Total Patients
164
Total Services
270
Medicare Billing
$25,037
Procedure Codes
12
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 15 | 28 | $10,568 | $3,189 | 30.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 13 | 19 | $4,535 | $1,286 | 28.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 11 | 14 | $3,618 | $959.29 | 26.5% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 12 | 27 | $16,787 | $4,431 | 26.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 14 | 39 | $11,214 | $3,413 | 30.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 12 | 17 | $5,216 | $1,787 | 34.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 18 | 21 | $4,228 | $1,233 | 29.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 11 | 14 | $3,078 | $1,097 | 35.6% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Facility | 2021 | 17 | 31 | $9,374 | $3,399 | 36.3% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Facility | 2020 | 16 | 26 | $6,941 | $2,220 | 32.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Facility | 2020 | 12 | 18 | $3,422 | $1,013 | 29.6% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 13 | 16 | $2,754 | $1,010 | 36.7% |
About Christopher Goss
Christopher Goss is a Pulmonary Disease healthcare provider based in Seattle, Washington. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/27/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457436289.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Christopher Goss has received a total of $62,687 in payments from pharmaceutical and medical device companies, with $11,500 received in 2021. These payments were reported across 63 transactions from 7 companies. The most common payment nature is "Consulting Fee" ($35,090).
As a Medicare-enrolled provider, Goss has provided services to 164 Medicare beneficiaries, totaling 270 services with total Medicare billing of $25,037. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Location Seattle, WA
- Active Since 10/27/2006
- Last Updated 09/06/2012
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1457436289
Products in Payments
- TOBI Podhaler (Drug) $2,327
- QUINSAIR (Drug) $750.00
- SPIRIVA RESPIMAT (Drug) $298.71
- ACTHAR (Biological) $11.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Seattle
Ganesh Raghu, Md, MD
Pulmonary Disease — Payments: $346,087
Pulmonary Disease $346,087
Jeffrey Cary, Md, MD
Pulmonary Disease — Payments: $170,288
Pulmonary Disease $170,288
Dr. Vinay Gupta, Md, MD
Pulmonary Disease — Payments: $166,440
Pulmonary Disease $166,440
Dr. Amy Dickey, Md, MD
Pulmonary Disease — Payments: $48,254
Pulmonary Disease $48,254
Reena Mehra, Md, MD
Pulmonary Disease — Payments: $37,758
Pulmonary Disease $37,758
Steven Kirtland, Md, MD
Pulmonary Disease — Payments: $31,534
Pulmonary Disease $31,534